The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
when we're talking about the a poor lipoproteins this gets a little confusing for people so when we're talking about chylomicrons with a PO be 48 and L do with a PO be 100 these are I think of these Davis saying boats I think of them as just hollow balls they're single single layer lipid membranes and they're full of triglyceride and cholesterol and they have these sort of marker proteins on them which identify them as LDL with a po be 100 or chylomicron with a April be 48
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
I'm not sure about endocytosis of chylomicrons I believe they can't be bound to LDL receptors because the get super technical here for a sec they haven't able B 48 as opposed to LDL having it able be 100 and it's actually called that because it's 48 percent of the max of the the other able lycra protein